Daisuke Asai

Prof. Daisuke Asai

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Biomaterials
Verified
Journal Article
Closed access
DADaisuke Asai
Daisuke Asai
DXDonghua Xu
Donghua Xu
WLWenge Liu
Wenge Liu
FQFelipe Garcia Quiroz
Felipe Garcia Quiroz
DCDaniel J. Callahan
Daniel J. Callahan
ACAshutosh Chilkoti
Ashutosh Chilkoti

1 January 1999 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MNMakoto Nakai
Makoto Nakai
YTYukiko Tabira
Yukiko Tabira
DADaisuke Asai
Daisuke Asai
YYYoshikuni Yakabe
Yoshikuni Yakabe
TSTeruo Shimyozu
Teruo Shimyozu
YSYasuyuki Shimohigashi
Yasuyuki Shimohigashi

15 May 1999 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
YTYukiko Tabira
Yukiko Tabira
MNMakoto Nakai
Makoto Nakai
DADaisuke Asai
Daisuke Asai
YYYoshikuni Yakabe
Yoshikuni Yakabe
YTYoshiko Tahara
Yoshiko Tahara
YSYasuyuki Shimohigashi
Yasuyuki Shimohigashi
Octyl‐ and nonylphenols in the environment have been proposed to function as estrogens. To gain insight into their structural essentials in binding to the estrogen receptor, a series of phenols with saturated alkyl groups at the para position, HO‐C6H4‐CnH2n+1 (n = 0–12), were examined for their ability to displace [3H]17β‐estradiol in the recombinant human estrogen receptor, which was expressed in Sf9 cells using the vaculovirus expression system. All tested para‐alkylphenols were found to bind fully to the estrogen receptors in a dose‐dependent manner. The interaction of alkylphenols with the receptor became stronger with increase in the number of the alkyl carbons and the activity was maximized with n = 9 of nonylphenol. Phenol (n = 0) exhibited weak but full binding to the receptor, whereas anisole with a protected phenolic hydroxyl group was completely inactive. Also, alkanes such as n‐octane, 2,2,4‐trimethylpentane corresponding to tert‐octane, and n‐nonane exhibited no binding. The results indicate that the binding of para‐alkylphenols to the estrogen receptor is due to the effect of covalent bonding of two constituents of the phenol and alkyl groups, which correspond to the A‐ring and hydrophobic moiety of the steroid structure, respectively. When alkylphenols were examined for their receptor binding conformation by 1H‐NMR measurements and ab initio molecular orbital calculations, it was suggested that nonbranched alkyl groups are in an extended conformation, while branched alkyl groups are in a folded conformation. These results suggest that branched and nonbranched alkyl moieties of alkylphenols interact differently with the lipophilic ligand binding cavity of the estrogen receptor when compared to the binding of 17β‐estradiol.

18 October 2008 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JKJeong-Hun Kang
Jeong-Hun Kang
DADaisuke Asai
Daisuke Asai
JKJong-Hwan Kim
Jong-Hwan Kim
TMTakeshi Mori
Takeshi Mori
RTRiki Toita
Riki Toita
YKYoshiki Katayama
Yoshiki Katayama

14 November 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
WLWenge Liu
Wenge Liu
JMJonathan McDaniel
Jonathan McDaniel
XLXinghai Li
Xinghai Li
DADaisuke Asai
Daisuke Asai
FQFelipe Garcia Quiroz
Felipe Garcia Quiroz
ACAshutosh Chilkoti
Ashutosh Chilkoti
Brachytherapy is a common clinical technique involving implantation of sealed radioactive “seeds” within a tumor to selectively irradiate the tumor mass while minimizing systemic toxicity. To mitigate the disadvantages associated with complex surgical implantation and subsequent device removal procedures, we have developed an alternative approach using a genetically encoded peptide polymer solution composed of a thermally responsive elastin-like polypeptide (ELP) radiolabeled with 131I that self-assembles into radionuclide seeds upon intratumoral injection. The formation of these nontoxic and biodegradable polymer seeds led to prolonged intratumoral retention (∼85% ID/tumor 7 days postinjection) of the radionuclide, elicited a tumor growth delay in 100% of the tumors in two human xenografts (FaDu and PC-3), and cured more than 67% of tumor-bearing animals after a single administration of labeled ELP. These results suggest that in situ self-assembly of biodegradable and injectable radionuclide-containing polypeptide seeds could be a promising therapeutic alternative to conventional brachytherapy. Cancer Res; 72(22); 5956–65. ©2012 AACR.

12 July 2012 in Biomacromolecules
Verified
Journal Article
Closed access
DXDonghua Xu
Donghua Xu
DADaisuke Asai
Daisuke Asai
ACAshutosh Chilkoti
Ashutosh Chilkoti
SCStephen L. Craig
Stephen L. Craig